Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_provenance.
- NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_assertion description "[SEL1L immunoreactivity can be detected both in the cytoplasm and less commonly in the nuclei; the subcellular location correlates with tumor histotype, with cytoplasmic immunoreactivity being most prevalent in squamous cell carcinomas (P = .0005) and nuclear immunoreactivity being associated with adenocarcinomas (P = .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_provenance.
- NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_assertion evidence source_evidence_literature NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_provenance.
- NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_assertion SIO_000772 16647946 NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_provenance.
- NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_assertion wasDerivedFrom befree-20150227 NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_provenance.
- NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_assertion wasGeneratedBy ECO_0000203 NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP689361.RATe_nC48Oj4qwBu6VaK247UCG_T2-dCU2JWquAWHnndg130_provenance.